Showing results (21-30 of 27) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Clinical and Translational Medicine|July 29, 2021
Tumor-derived exosomal BCYRN1 activates WNT5A/VEGF-C/VEGFR3 feedforward loop to drive lymphatic metastasis of bladder cancerHanhao Zheng, Changhao Chen, Yuming Luo, et al.Oncology Letters|July 3, 2018
Muscarinic cholinergic signaling and overactive bladder-like symptoms associated with invasive bladder cancerWei Wei, Minggang Wang, Yunglong Li, et al.BJU International|September 9, 2022
Randomized controlled trial of intravesical electrical stimulation for underactive bladderLimin Liao, Han Deng, Guoqing Chen, et al.BJU International|April 19, 2016
Results of a randomized, double-blind, active-controlled clinical trial with propiverine extended release 30 mg in patients with overactive bladderJing Leng, Limin Liao, Ben Wan, et al.Journal of Experimental & Clinical Cancer Research : CR|June 22, 2021
Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancerJingtong Zhang, Qianghua Zhou, Keji Xie, et al.Asian Journal of Urology|December 22, 2017
A phase 3, double-blind, randomized placebo-controlled efficacy and safety study of abiraterone acetate in chemotherapy-naïve patients with mCRPC in China, Malaysia, Thailand and RussiaDingwei Ye, Yiran Huang, Fangjian Zhou, et al.Frontiers in Pharmacology|March 7, 2022
Hengli® Chinese Botulinum Toxin Type A for Treatment of Patients With Overactive Bladder: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled TrialLimin Liao, Qinggang Liu, Huiling Cong, et al.Pageof 3